We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Helen of Troy
HELE
$649M
| $5.97M | 0.01% |
63,400
+1,731
| +3% | +$163K |
|
902
iShares Russell 1000 Growth ETF
IWF
$120B
| $5.97M | 0.01% |
209,852
-132,756
| -39% | -$3.68M |
|
|
B
903
DELISTED
Barnes Group Inc.
B
| $5.93M | 0.01% |
115,593
+28,854
| +33% | +$1.41M |
|
|
SJI
904
DELISTED
South Jersey Industries, Inc.
SJI
| $5.93M | 0.01% |
166,458
+43,081
| +35% | +$1.44M |
|
905
Selective Insurance
SIGI
$5.64B
| $5.93M | 0.01% |
125,824
+33,065
| +36% | +$1.47M |
|
906
Axalta
AXTA
$7.71B
| $5.92M | 0.01% |
183,741
+7,234
| +4% | +$215K |
|
|
BCPC
907
Balchem Corp
BCPC
$5.23B
| $5.9M | 0.01% |
71,615
+13,996
| +24% | +$1.18M |
|
|
CADE
908
DELISTED
Cadence Bank
CADE
| $5.88M | 0.01% |
194,449
+3,603
| +2% | +$111K |
|
|
MIC
909
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $5.87M | 0.01% |
72,897
+4,488
| +7% | +$355K |
|
910
H.B. Fuller
FUL
$2.98B
| $5.87M | 0.01% |
113,766
+28,871
| +34% | +$1.44M |
|
911
Under Armour Class C
UA
$2.85B
| $5.85M | 0.01% |
319,775
+7,178
| +2% | +$150K |
|
|
ESL
912
DELISTED
Esterline Technologies
ESL
| $5.85M | 0.01% |
67,937
+1,637
| +2% | +$143K |
|
|
BWLD
913
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $5.83M | 0.01% |
38,174
-187
| -0.5% | -$28.6K |
|
914
Cable One
CABO
$224M
| $5.82M | 0.01% |
9,323
+242
| +3% | +$151K |
|
|
EFOR
915
Everforth Inc
EFOR
$1.13B
| $5.82M | 0.01% |
119,863
+27,029
| +29% | +$1.25M |
|
916
Euronet Worldwide
EEFT
$2.92B
| $5.81M | 0.01% |
67,935
+1,788
| +3% | +$141K |
|
|
VSM
917
DELISTED
Versum Materials, Inc.
VSM
| $5.79M | 0.01% |
189,364
+5,337
| +3% | +$156K |
|
918
Advanced Energy
AEIS
$11B
| $5.77M | 0.01% |
84,186
+22,498
| +36% | +$1.39M |
|
919
Lumentum
LITE
$53.9B
| $5.77M | 0.01% |
108,078
+31,294
| +41% | +$1.38M |
|
|
SRC
920
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $5.76M | 0.01% |
126,808
+13,142
| +12% | +$626K |
|
921
Community Bank
CBU
$3.42B
| $5.76M | 0.01% |
104,742
+23,972
| +30% | +$1.4M |
|
|
ACH
922
Accendra Health
ACH
$256M
| $5.75M | 0.01% |
166,244
-6,700
| -4% | -$239K |
|
|
KATE
923
DELISTED
Kate Spade & Company
KATE
| $5.75M | 0.01% |
247,574
+9,395
| +4% | +$196K |
|
|
CAVM
924
DELISTED
Cavium, Inc.
CAVM
| $5.75M | 0.01% |
80,190
+2,852
| +4% | +$191K |
|
925
lululemon athletica
LULU
$13.6B
| $5.72M | 0.01% |
110,308
+3,871
| +4% | +$255K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.